← Signal Board

Protagonist Therapeutics financial statements

프로타고니스트 테라퓨틱스NASDAQ:PTGX · Nasdaq · Healthcare · sector #17
$138.69-1.38%
2026-10-06 close

Protagonist Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $434M. 2024 operating profit was $253M.

Reported results

Protagonist Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy